Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma-Reference-Cited by-同舟云学术

Clinical heterogeneity in patients with non-alcoholic fatty liver disease-associated hepatocellular carcinoma

Published:2020-09-01 Issue:11 Volume:14 Page:1025-1033
ISSN:1747-4124
Container-title:Expert Review of Gastroenterology & Hepatology
language:en
Short-container-title:Expert Review of Gastroenterology & Hepatology

Author:

Anastasopoulos Nikolaos-Andreas T.¹²,Lianos Georgios D.²,Tatsi Vera²,Karampa Anastasia²,Goussia Anna³,Glantzounis Georgios K.²^ORCID

Affiliation:

1. First Propaedeutic Department of General Surgery, National and Kapodistrian University of Athens, “Hippokrateion” General Hospital of Athens, Athens, Greece

2. Department of Surgery, University Hospital of Ioannina and School of Medicine, University of Ioannina, Ioannina, Greece

3. Department of Pathology, University Hospital of Ioannina and School of Medicine, University of Ioannina, Ioannina, Greece

Funder

declared

Publisher

Informa UK Limited

Subject

Gastroenterology,Hepatology

Link

https://www.tandfonline.com/doi/pdf/10.1080/17474124.2020.1802244

Reference95 articles.

1. EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study

4. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis

5. Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. The Role of Oxidative Stress and Cellular Senescence in the Pathogenesis of Metabolic Associated Fatty Liver Disease and Related Hepatocellular Carcinoma;Antioxidants;2023-06-14

3. Real world for management of hepatocellular carcinoma: a large population-based study;Scandinavian Journal of Gastroenterology;2023-05-18

4. IFC in Primary and Metastatic Liver Tumours;Intraoperative Flow Cytometry;2023

5. “Liver–gut” axis: A target of traditional Chinese medicine for the treatment of non-alcoholic fatty liver disease;Frontiers in Endocrinology;2022-11-30